159 related articles for article (PubMed ID: 34397915)
1. Prognostic similarity between ovarian mucinous carcinoma with expansile invasion and ovarian mucinous borderline tumor: A retrospective analysis.
Hada T; Miyamoto M; Ishibashi H; Matsuura H; Sakamoto T; Kakimoto S; Iwahashi H; Suzuki R; Sato K; Tsuda H; Takano M
Medicine (Baltimore); 2021 Aug; 100(32):e26895. PubMed ID: 34397915
[TBL] [Abstract][Full Text] [Related]
2. Genetic analysis for mucinous ovarian carcinoma with infiltrative and expansile invasion and mucinous borderline tumor: a retrospective analysis.
Hada T; Miyamoto M; Ohtsuka Y; Suminokura J; Ito T; Kishimoto N; Nishitani S; Takada M; Imauji A; Tanabe R; Takano M
Diagn Pathol; 2023 Apr; 18(1):49. PubMed ID: 37081552
[TBL] [Abstract][Full Text] [Related]
3. Comparison of clinical behavior between mucinous ovarian carcinoma with infiltrative and expansile invasion and high-grade serous ovarian carcinoma: a retrospective analysis.
Hada T; Miyamoto M; Ishibashi H; Matsuura H; Kakimoto S; Iwahashi H; Tsuda H; Takano M
Diagn Pathol; 2022 Jan; 17(1):12. PubMed ID: 35057833
[TBL] [Abstract][Full Text] [Related]
4. Survival and biomarker analysis for ovarian mucinous carcinoma according to invasive patterns: retrospective analysis and review literature.
Hada T; Miyamoto M; Ishibashi H; Matsuura H; Sakamoto T; Kakimoto S; Iwahashi H; Tsuda H; Takano M
J Ovarian Res; 2021 Feb; 14(1):33. PubMed ID: 33583413
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of patients with early stage mucinous ovarian carcinoma: a Dutch population-based cohort study comparing expansile and infiltrative subtypes.
Algera MD; Van de Vijver KK; van Driel WJ; Slangen BFM; Lof FC; van der Aa M; Kruitwagen RFPM; Lok CAR
Int J Gynecol Cancer; 2024 May; 34(5):722-729. PubMed ID: 38460968
[TBL] [Abstract][Full Text] [Related]
6. Histological classification of mucinous ovarian tumors: inter-observer reproducibility, clinical relevance, and role of genetic biomarkers.
Genestie C; Auguste A; Al Battal M; Scoazec JY; Gouy S; Lacroix L; Morice P; Pautier P; Leary A; Devouassoux-Shisheboran M
Virchows Arch; 2021 May; 478(5):885-891. PubMed ID: 33009577
[TBL] [Abstract][Full Text] [Related]
7. Refined criteria for p53 expression in ovarian mucinous tumours are highly concordant with TP53 mutation status, but p53 expression/TP53 status lack prognostic significance.
Dundr P; Hájková N; Kendall Bártů M; Cibula D; Drozenová J; Fabian P; Fadare O; Frühauf F; Hausnerová J; Hojný J; Laco J; Lax SF; Matěj R; Méhes G; Michálková R; Němejcová K; Singh N; Stolnicu S; Švajdler M; Zima T; McCluggage WG; Stružinská I
Pathology; 2023 Oct; 55(6):785-791. PubMed ID: 37500307
[TBL] [Abstract][Full Text] [Related]
8. Mucinous borderline ovarian tumors: pathological and prognostic study at Salah Azaiez Institute.
Sahraoui G; Fitouri A; Charfi L; Driss M; Slimane M; Hechiche M; Mrad K; Doghri R
Pan Afr Med J; 2022; 41():349. PubMed ID: 35909430
[TBL] [Abstract][Full Text] [Related]
9. Invasion patterns in stage I endometrioid and mucinous ovarian carcinomas: a clinicopathologic analysis emphasizing favorable outcomes in carcinomas without destructive stromal invasion and the occasional malignant course of carcinomas with limited destructive stromal invasion.
Chen S; Leitao MM; Tornos C; Soslow RA
Mod Pathol; 2005 Jul; 18(7):903-11. PubMed ID: 15696121
[TBL] [Abstract][Full Text] [Related]
10. Characteristics and Prognosis of Stage I Ovarian Mucinous Tumors According to Expansile or Infiltrative Type.
Gouy S; Saidani M; Maulard A; Bach-Hamba S; Bentivegna E; Leary A; Pautier P; Devouassoux-Shisheboran M; Genestie C; Morice P
Int J Gynecol Cancer; 2018 Mar; 28(3):493-499. PubMed ID: 29466254
[TBL] [Abstract][Full Text] [Related]
11. Mucinous tumors of the ovary: a clinicopathologic analysis of 75 borderline tumors (of intestinal type) and carcinomas.
Rodríguez IM; Prat J
Am J Surg Pathol; 2002 Feb; 26(2):139-52. PubMed ID: 11812936
[TBL] [Abstract][Full Text] [Related]
12. Mucinous tumors of the ovary: a clinicopathologic study of 196 borderline tumors (of intestinal type) and carcinomas, including an evaluation of 11 cases with 'pseudomyxoma peritonei'.
Lee KR; Scully RE
Am J Surg Pathol; 2000 Nov; 24(11):1447-64. PubMed ID: 11075847
[TBL] [Abstract][Full Text] [Related]
13. Primary ovarian mucinous carcinoma of intestinal type: significance of pattern of invasion and immunohistochemical expression profile in a series of 31 cases.
Tabrizi AD; Kalloger SE; Köbel M; Cipollone J; Roskelley CD; Mehl E; Gilks CB
Int J Gynecol Pathol; 2010 Mar; 29(2):99-107. PubMed ID: 20173494
[TBL] [Abstract][Full Text] [Related]
14. TP53 as a Diagnostic Aid in the Distinction of Ovarian Mucinous Borderline Tumors From Mucinous Carcinoma.
Kang EY; Terzic T; Ghatage P; Woo L; Gorringe KL; Karnezis AN; Lee CH; Köbel M
Int J Gynecol Pathol; 2024 Mar; 43(2):111-122. PubMed ID: 37406453
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of diagnostic criteria and behavior of ovarian intestinal-type mucinous tumors: atypical proliferative (borderline) tumors and intraepithelial, microinvasive, invasive, and metastatic carcinomas.
Riopel MA; Ronnett BM; Kurman RJ
Am J Surg Pathol; 1999 Jun; 23(6):617-35. PubMed ID: 10366144
[TBL] [Abstract][Full Text] [Related]
16. Primary Mucinous Tumors of the Ovary: An Interobserver Reproducibility and Detailed Molecular Study Reveals Significant Overlap Between Diagnostic Categories.
Dundr P; Bártů M; Bosse T; Bui QH; Cibula D; Drozenová J; Fabian P; Fadare O; Hausnerová J; Hojný J; Hájková N; Jakša R; Laco J; Lax SF; Matěj R; Méhes G; Michálková R; Šafanda A; Němejcová K; Singh N; Stolnicu S; Švajdler M; Zima T; Stružinská I; McCluggage WG
Mod Pathol; 2023 Jan; 36(1):100040. PubMed ID: 36788074
[TBL] [Abstract][Full Text] [Related]
17. Results of Fertility-Sparing Surgery for Expansile and Infiltrative Mucinous Ovarian Cancers.
Gouy S; Saidani M; Maulard A; Bach-Hamba S; Bentivegna E; Leary A; Pautier P; Devouassoux-Shisheboran M; Genestie C; Morice P
Oncologist; 2018 Mar; 23(3):324-327. PubMed ID: 29242280
[TBL] [Abstract][Full Text] [Related]
18. Outcome-based Validation of Confluent/Expansile Versus Infiltrative Pattern Assessment and Growth-based Grading in Ovarian Mucinous Carcinoma.
Momeni-Boroujeni A; Song H; Irshaid L; Strickland S; Parra-Herran C; Busca A
Am J Surg Pathol; 2022 Sep; 46(9):1250-1259. PubMed ID: 35363158
[TBL] [Abstract][Full Text] [Related]
19. The clinicopathological characteristics and survival outcomes of primary expansile
Nistor S; El-Tawab S; Wong F; Zouridis A; Roux R; Manek S; Gaitskell K; Ahmed AA; Kehoe S; Soleymani Majd H
Transl Cancer Res; 2023 Oct; 12(10):2682-2692. PubMed ID: 37969399
[TBL] [Abstract][Full Text] [Related]
20. Primary ovarian mucinous adenocarcinoma of intestinal type: a clinicopathologic study of 46 cases.
Khunamornpong S; Settakorn J; Sukpan K; Suprasert P; Siriaunkgul S
Int J Gynecol Pathol; 2014 Mar; 33(2):176-85. PubMed ID: 24487473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]